CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,408 | -40.4% | 9,723 | -9.1% | 0.04% | -39.4% |
| Q2 2023 | $111,411 | +13.3% | 10,692 | -24.2% | 0.07% | +22.2% |
| Q1 2023 | $98,375 | -16.5% | 14,114 | -27.8% | 0.05% | -12.9% |
| Q4 2022 | $117,796 | +93.1% | 19,535 | +152.6% | 0.06% | +158.3% |
| Q3 2022 | $61,000 | -41.3% | 7,733 | +0.7% | 0.02% | -38.5% |
| Q2 2022 | $104,000 | +31.6% | 7,676 | +90.6% | 0.04% | +11.4% |
| Q1 2022 | $79,000 | -45.9% | 4,028 | -5.4% | 0.04% | -36.4% |
| Q4 2021 | $146,000 | +24.8% | 4,258 | +98.0% | 0.06% | +7.8% |
| Q3 2021 | $117,000 | -29.5% | 2,150 | -4.8% | 0.05% | -25.0% |
| Q2 2021 | $166,000 | -26.9% | 2,259 | -8.9% | 0.07% | -29.2% |
| Q1 2021 | $227,000 | +14.6% | 2,480 | +1.8% | 0.10% | +17.1% |
| Q4 2020 | $198,000 | – | 2,437 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |